|
|
|
|
LEADER |
00000cam a2200000 i 4500 |
001 |
EBOOKCENTRAL_ocn951621500 |
003 |
OCoLC |
005 |
20240329122006.0 |
006 |
m o d i |
007 |
cr un||||||||| |
008 |
160613t20162016au a ob i000 0 eng d |
040 |
|
|
|a COD
|b eng
|e rda
|e pn
|c COD
|d OCLCF
|d EBLCP
|d MERUC
|d COCUF
|d LOA
|d K6U
|d OCLCQ
|d STF
|d ZCU
|d WRM
|d OCLCQ
|d OCLCA
|d EZ9
|d ICG
|d VT2
|d OCLCO
|d OCLCQ
|d WYU
|d LVT
|d TKN
|d DKC
|d AU@
|d OCLCO
|d OCLCQ
|d YDX
|d OCLCQ
|d OCLCA
|d OCLCO
|d OCLCQ
|d OCLCO
|d OCLCQ
|
019 |
|
|
|a 1055381045
|a 1081266470
|
020 |
|
|
|z 9789201112156
|
020 |
|
|
|z 9201112157
|
035 |
|
|
|a (OCoLC)951621500
|z (OCoLC)1055381045
|z (OCoLC)1081266470
|
050 |
|
4 |
|a RC78.7.R4
|b G66 2016eb
|
060 |
|
4 |
|a 2018 E-686
|
060 |
|
4 |
|a WN 445
|
082 |
0 |
4 |
|a 616.07575
|2 23
|
049 |
|
|
|a UAMI
|
245 |
0 |
0 |
|a Good practice for introducing radiopharmaceuticals for clinical use.
|
264 |
|
1 |
|a Vienna :
|b International Atomic Energy Agency,
|c 2016.
|
264 |
|
4 |
|c ©2016
|
300 |
|
|
|a 1 online resource (65 pages) :
|b illustrations
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
490 |
1 |
|
|a IAEA-TECDOC-1782,
|x 1011-4289
|
500 |
|
|
|a "Alasbimn, AOFNMB, EANM, SNMMI, WFNMB."
|
500 |
|
|
|a "February 2016"--Tit;e page verso.
|
504 |
|
|
|a Includes bibliographical references (pages 61-62).
|
520 |
|
|
|a "The use of new radiopharmaceuticals can provide extremely valuable information in the evaluation of cancer, as well as heart and brain diseases --- information that often times cannot be obtained by other means. However, there is a perceived need in many Member States for a useful reference to facilitate and expedite the introduction of radiopharmaceuticals already in clinical use in other countries. This publication intends to provide practical support for the introduction of new radiotracers, including recommendations on the necessary steps needed to facilitate and expedite the introduction of radiopharmaceuticals in clinical use, while ensuring that a safe and high quality product is administered to the patient at all times."--Publisher's description.
|
588 |
0 |
|
|a Print version record.
|
590 |
|
|
|a ProQuest Ebook Central
|b Ebook Central Academic Complete
|
650 |
|
0 |
|a Radiopharmaceuticals.
|
650 |
|
0 |
|a Radioisotopes in medical diagnosis.
|
650 |
|
0 |
|a Nuclear medicine.
|
650 |
1 |
2 |
|a Radiopharmaceuticals
|
650 |
2 |
2 |
|a Radioisotopes
|x therapeutic use
|
650 |
2 |
2 |
|a Nuclear Medicine
|
650 |
|
6 |
|a Radiopharmaceutiques.
|
650 |
|
6 |
|a Isotopes radioactifs dans le diagnostic.
|
650 |
|
6 |
|a Médecine nucléaire.
|
650 |
|
7 |
|a Nuclear medicine
|2 fast
|
650 |
|
7 |
|a Radioisotopes in medical diagnosis
|2 fast
|
650 |
|
7 |
|a Radiopharmaceuticals
|2 fast
|
710 |
2 |
|
|a International Atomic Energy Agency,
|e issuing body,
|e publisher.
|
710 |
2 |
|
|a Asociación Latinoamericana de Sociedades de Biología y Medicina Nuclear,
|e sponsoring body.
|
710 |
2 |
|
|a Asia Oceania Federation of Nuclear Medicine & Biology,
|e sponsoring body.
|
710 |
2 |
|
|a European Association of Nuclear Medicine,
|e sponsoring body.
|
710 |
2 |
|
|a Society of Nuclear Medicine and Molecular Imaging,
|e sponsoring body.
|
710 |
2 |
|
|a World Federation of Nuclear Medicine and Biology,
|e sponsoring body.
|
776 |
0 |
8 |
|i Print version:
|t Good practice for introducing radiopharmaceuticals for clinical use.
|d Vienna : International Atomic Energy Agency, 2016
|z 9789201112156
|w (OCoLC)946358807
|
830 |
|
0 |
|a IAEA-TECDOC ;
|v 1782.
|
856 |
4 |
0 |
|u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=4853318
|z Texto completo
|
938 |
|
|
|a EBL - Ebook Library
|b EBLB
|n EBL4853318
|
938 |
|
|
|a YBP Library Services
|b YANK
|n 16497527
|
994 |
|
|
|a 92
|b IZTAP
|